Zobrazeno 1 - 10
of 158
pro vyhledávání: '"FATEMA NADER"'
Autor:
Saleh A. Alqahtani, Khalid Alswat, Mohamed Mawardi, Faisal M. Sanai, Faisal Abaakhail, Saad Alghamdi, Waleed K. Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M. Younossi
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 5, Pp 335-341 (2024)
Background: A recent name change of nonalcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD) to metabolic dysfunction-associated steatotic liver disease was primarily driven by potential stigma associat
Externí odkaz:
https://doaj.org/article/828bc2bf207f48429acd48f959b18d93
Autor:
Zobair M. Younossi, Saleh A. AlQahtani, Jesús Funuyet-Salas, Manuel Romero-Gómez, Yusuf Yilmaz, Caglayan Keklikkiran, Khalid Alswat, Ming-Lung Yu, Chun-Jen Liu, Jian-Gao Fan, Ming-Hua Zheng, Patrizia Burra, Sven M. Francque, Laurent Castera, Jörn M. Schattenberg, Philip N. Newsome, Alina M. Allen, Mohamed El-Kassas, Sombat Treeprasertsuk, Saeed Hameed, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Hirokazu Takahashi, Takumi Kawaguchi, Marlen I. Castellanos Fernández, Ajay Duseja, Marco Arrese, Mary Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Wayne Eskridge, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, Moises Diago, Lynn Gerber, Brian Lam, Lisa Fornaresio, Fatema Nader, C. Wendy Spearman, Stuart K. Roberts, Wah-Kheong Chan, Marcelo Silva, Andrei Racila, Pegah Golabi, Prooksa Ananchuensook, Linda Henry, Maria Stepanova, Patrizia Carrieri, Jeffrey V. Lazarus
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101066- (2024)
Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality of life (HRQL) and potential
Externí odkaz:
https://doaj.org/article/89eb6d0343c440378b078cf55412cc72
Autor:
Zobair M. Younossi, Yusuf Yilmaz, Mohamed El‐Kassas, Ajay Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez‐Sánchez, Wah Kheong Chan, Ashwani K. Singal, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian K. Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova
Publikováno v:
Hepatology Communications, Vol 6, Iss 10, Pp 2860-2866 (2022)
Abstract Patients with preexisting chronic liver disease (CLD) may experience a substantial burden from both coronavirus 2019 (COVID‐19) infection and pandemic‐related life disruption. We assessed the impact of the COVID‐19 pandemic on patients
Externí odkaz:
https://doaj.org/article/84014429ef074574bdf4a6a0d13c9f95
Autor:
Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveiro-Barciela, Fatema Nader, Luisa Roade, Rafael Esteban, Zobair Younossi
Publikováno v:
JHEP Reports, Vol 4, Iss 9, Pp 100526- (2022)
Externí odkaz:
https://doaj.org/article/341b39cec1464e8aa23735846db24ebd
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States
Autor:
Zobair M. Younossi, James M. Paik, Linda Henry, Joe Yang, Gail Fernandes, Maria Stepanova, Fatema Nader
Publikováno v:
Journal of Clinical and Experimental Hepatology. 13:454-467
Autor:
Jillian Kallman Price, Lynn H Gerber, Maria Stepanova, Leyla de Avila, Ali A Weinstein, Huong Pham, Fatema Nader, Mariam Afendy, Kathy Terra, Patrick Austin, Wisna’odom Keo, Andrei Racila, James Michael Estep, Suzannah Gerber, Manisha Verma, Pegah Golabi, Brian P Lam, Zobair Younossi
Publikováno v:
International Journal of General Medicine. 16:1479-1490
Jillian Kallman Price,1 Lynn H Gerber,1,2 Maria Stepanova,1â 3 Leyla de Avila,1 Ali A Weinstein,4 Huong Pham,1 Fatema Nader,1 Mariam Afendy,1 Kathy Terra,3 Patrick Austin,1 Wisnaâodom Keo,1 Andrei Racila,1 James Michael Estep,1 Suzannah Ger
Autor:
Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveiro-Barciela, Fatema Nader, Luisa Roade, Rafael Esteban, Zobair Younossi
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100280- (2021)
Background & Aims: Health-related quality of life (HRQoL) determined by patient-reported outcomes (PROs) is impaired in chronic hepatitis B (CHB) and C patients, but there are no data regarding patients with chronic hepatitis D (CHD). The aim of this
Externí odkaz:
https://doaj.org/article/c5867719915c497d8b09d0bcbd1830da
Autor:
Leyla de Avila, Jillian K. Price, Maria Stepanova, Brian Lam, Ali A. Weinstein, Huong Pham, Patrick Austin, Wisna Keo, Zaid Younossi, Mariam Afendy, Samir Nader, Kathy Terra, Rebecca Cable, Elena Younossi, Pegah Golabi, Manisha Verma, Fatema Nader, Andrei Racila, Lynn H. Gerber, Zobair M. Younossi
Publikováno v:
American Journal of Physical Medicine & Rehabilitation. 102:433-443
Autor:
Zobair M. Younossi, Ming‐Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S. Hamid, Mohamed El‐Kassas, Wah Kheong Chan, Ajay K. Duseja, Stuart C. Gordon, Yuichiro Eguchi, Vasily A. Isakov, Stuart K. Roberts, Jian‐Gao Fan, Ashwani K. Singal, Manuel Romero‐Gómez, Aijaz Ahmed, Janus Ong, Brian P. Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Publikováno v:
Journal of Viral Hepatitis. 30:335-344
Chronic hepatitis B (CHB) infection is one of the most common causes of cirrhosis and liver cancer worldwide. Our aim was to assess clinical and patient-reported outcome (PRO) profile of CHB patients from different regions of the world using the Glob
Publikováno v:
Liver International. 42:2646-2661
Fatigue among patients with NAFLD may negatively impact their health-related quality of life and clinical outcomes (mortality). We determined fatigue prevalence and its association with all-cause mortality among patients with NAFLD.NHANES 2005-2010 a